Literature DB >> 36169678

The potential mechanism of the microbiota-gut-bone axis in osteoporosis: a review.

Yinxi He1, Yanxia Chen2.   

Abstract

Osteoporosis is the prevalent metabolic bone disease characterized by a decrease in bone quantity and/or quality and an increase in skeletal fragility, which increases susceptibility to fractures. Osteoporotic fractures severely affect the patients' quality of life and mortality. A plethora of evidences have suggested that the alterations in gut microbiome are associated with the changes in bone mass and microstructure. We summarized pre-clinical and clinical studies to elucidate the underlying mechanism of gut microbiota in osteoporosis. Probiotics, prebiotics, and traditional Chinese medicine may reverse the gut microbiota dysbiosis and consequently improve bone metabolism. However, the causality of gut microbiota on bone metabolism need to be investigated more in depth. In the present review, we focused on the potential mechanism of the microbiota-gut-bone axis and the positive therapeutic effect of probiotics, prebiotics, and traditional Chinese medicine on osteoporosis. Overall, the current scientific literatures support that the gut microbiota may be a novel therapeutic target in treatment of osteoporosis and fracture prevention.
© 2022. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.

Entities:  

Keywords:  Gut microbiota; Osteoporosis; Prebiotics; Probiotics; Traditional Chinese medicine

Year:  2022        PMID: 36169678     DOI: 10.1007/s00198-022-06557-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  111 in total

Review 1.  Bone Health During the Menopause Transition and Beyond.

Authors:  Arun S Karlamangla; Sherri-Ann M Burnett-Bowie; Carolyn J Crandall
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  Osteoporosis Prevention and Management.

Authors:  Muralidhar V Pai
Journal:  J Obstet Gynaecol India       Date:  2017-04-20

Review 3.  Diversity, stability and resilience of the human gut microbiota.

Authors:  Catherine A Lozupone; Jesse I Stombaugh; Jeffrey I Gordon; Janet K Jansson; Rob Knight
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

Review 4.  Human gut microbiome: the second genome of human body.

Authors:  Baoli Zhu; Xin Wang; Lanjuan Li
Journal:  Protein Cell       Date:  2010-08-28       Impact factor: 14.870

Review 5.  The microbiota-gut-brain axis in obesity.

Authors:  Cristina Torres-Fuentes; Harriët Schellekens; Timothy G Dinan; John F Cryan
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-08-24

Review 6.  Gut microbiota in the pathogenesis of inflammatory bowel disease.

Authors:  Atsushi Nishida; Ryo Inoue; Osamu Inatomi; Shigeki Bamba; Yuji Naito; Akira Andoh
Journal:  Clin J Gastroenterol       Date:  2017-12-29

Review 7.  Bone remodeling.

Authors:  Dimitrios J Hadjidakis; Ioannis I Androulakis
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

8.  Global investigation of composition and interaction networks in gut microbiomes of individuals belonging to diverse geographies and age-groups.

Authors:  Deepak Yadav; Tarini Shankar Ghosh; Sharmila S Mande
Journal:  Gut Pathog       Date:  2016-05-06       Impact factor: 4.181

Review 9.  Implication of Gut Microbiota in Cardiovascular Diseases.

Authors:  Wenyi Zhou; Yiyu Cheng; Ping Zhu; M I Nasser; Xueyan Zhang; Mingyi Zhao
Journal:  Oxid Med Cell Longev       Date:  2020-09-26       Impact factor: 6.543

Review 10.  New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.

Authors:  Yanxia Chen; Mian Wang
Journal:  Drug Des Devel Ther       Date:  2021-11-30       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.